1. Home
  2. FNWD vs CRDL Comparison

FNWD vs CRDL Comparison

Compare FNWD & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNWD
  • CRDL
  • Stock Information
  • Founded
  • FNWD 1994
  • CRDL 2017
  • Country
  • FNWD United States
  • CRDL Canada
  • Employees
  • FNWD N/A
  • CRDL N/A
  • Industry
  • FNWD Savings Institutions
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FNWD Finance
  • CRDL Health Care
  • Exchange
  • FNWD Nasdaq
  • CRDL Nasdaq
  • Market Cap
  • FNWD 123.1M
  • CRDL 126.5M
  • IPO Year
  • FNWD N/A
  • CRDL N/A
  • Fundamental
  • Price
  • FNWD $29.61
  • CRDL $1.31
  • Analyst Decision
  • FNWD Buy
  • CRDL Strong Buy
  • Analyst Count
  • FNWD 1
  • CRDL 2
  • Target Price
  • FNWD $34.00
  • CRDL $9.00
  • AVG Volume (30 Days)
  • FNWD 85.9K
  • CRDL 1.2M
  • Earning Date
  • FNWD 07-29-2025
  • CRDL 08-26-2025
  • Dividend Yield
  • FNWD 1.62%
  • CRDL N/A
  • EPS Growth
  • FNWD N/A
  • CRDL N/A
  • EPS
  • FNWD 1.24
  • CRDL N/A
  • Revenue
  • FNWD $63,780,000.00
  • CRDL N/A
  • Revenue This Year
  • FNWD N/A
  • CRDL N/A
  • Revenue Next Year
  • FNWD $6.97
  • CRDL N/A
  • P/E Ratio
  • FNWD $23.82
  • CRDL N/A
  • Revenue Growth
  • FNWD N/A
  • CRDL N/A
  • 52 Week Low
  • FNWD $26.12
  • CRDL $0.77
  • 52 Week High
  • FNWD $33.50
  • CRDL $2.63
  • Technical
  • Relative Strength Index (RSI)
  • FNWD 64.37
  • CRDL 51.92
  • Support Level
  • FNWD $27.12
  • CRDL $0.94
  • Resistance Level
  • FNWD $30.59
  • CRDL $1.55
  • Average True Range (ATR)
  • FNWD 0.95
  • CRDL 0.13
  • MACD
  • FNWD 0.29
  • CRDL -0.00
  • Stochastic Oscillator
  • FNWD 71.84
  • CRDL 59.74

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: